Abstract: In one embodiment, the present invention relates to novel mu-conotoxin peptides, biologically active fragments thereof, combinations thereof and/or variants thereof. An embodiment of the invention also relates to their use in pharmaceutical composition for the treatment or prevention of pain, and their use in the preparation of an anesthetic.
Type:
Application
Filed:
November 8, 2006
Publication date:
April 12, 2012
Applicants:
Centre National de la Recherche Scientifique (C.N.R.S.), Atheris Laboratories
Inventors:
Philippe Favreau, Evelyne Benoit, Jordi Molgo, Reto Stöcklin